Jointechlabs is a California based point-of-care regenerative medicine company with FDA-cleared technology. Aging causes a lot of pain and suffering, and people are not able to do things they love or look and feel the same anymore. Regenerative Med enhances life and reverses aspects of aging by using your own natural cells, but it has not panned out as a standard of care because of the lack of accessibility to the technology at the local clinic and hospital. With MiniTC (FDA-cleared) and Mini-Stem System (CE Mark pending), 8 granted patents, signed distributor contracts, early sales, and several pipeline therapeutic products, Jointechlabs is creating an ecosystem of regenerative medicine devices, therapies and services which will establish a standard of care. Our products:1) US FDA-CLEARED MiniTC®Patented, portable, disposable medical device that processes human fat at the point-of-care to isolate injectable microfat for regenerative medicine treatments.2) EU CE-Mark pending Mini-Stem System®Patented, portable, disposable medical devices that process human fat at the point-of-care to isolate injectable stem cell fraction (SVF) for regenerative medicine treatments.3) Pipeline Therapeutic product JTL-T-01Based on our platform and technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. 4) Tissue 3D printing We are working on tissue 3D printing based on a combination of our devices with existing portable 3D bioprinting device, and proprietary scaffold hydrogels which will provide unique opportunity for development of breakthrough therapies for unmet medical needs. Target Markets: 1) Medical Aesthetics 2) Plastic & Reconstructive Surgery 3) Orthopedics and Sports Medicine 4) Wound Healing

VivaStem Laboratories is the pioneer in stem cell fluid technology, a technology which is a result of more than 12 years of rigorous research. Founded in 2011, VivaStem Laboratories provides innovative off-the-shelf non-cellular stem cell therapy, currently for veterinary use. We are also developing similar products for potential use in humans. www.vivastem.com

Stem cell research and developmentPublications:Culture of omentum-induced regenerating liver yielded hepatocyte-committed stem cellsTranslational ResearchOmentum facilitates liver regenerationWorld Journal of Gastroenterology Stem cells cultured from omentum-induced regenerating liver can be differentiated to hepatocytesJournal of Investigative MedicineAdult stem cells from foreign-body granulation tissue protect the kidney and accelerate recovery from acute kidney injuryJournal of American Society of NephrologyStellate-like mesenchymal stem cells cultured from omentum-induced regenerating liver tissueGastroenterologyFusion of activated omentum with kidney attenuates progression of chronic kidney diseaseJournal of American Society of NephrologyAsymptomatic microalbuminuria in HIV+ African AmericansJournal of American Society of NephrologyStem cells from foreign body granulation tissue accelerate recovery from acute kidney injuryNephrology Dialysis Transplantation